FDA Permits Marketing of New Tissue Expander for Women Undergoing Breast Reconstruction Following Mastectomy

22 dicembre 2016 – On December 21, the U.S. Food and Drug Administration (FDA) allowed marketing of a new tissue-expander system for soft-tissue expansion in two-stage breast reconstruction following mastectomy and in the treatment of underdeveloped breasts and soft-tissue deformities. A patient uses a dose controller to independently inflate the expander. A tissue expander is a balloon-like device that has a soft, expandable polymer shell and is gradually filled with … (leggi tutto)